Ringer’s injection

Intravenous replacement solutions are a source of electrolytes and water for hydration (Normosol M Ringer s Injection, Lactated Ringer s, Plasma-Lyte R), and used to facilitate amino acid utilization and maintain electrolyte balance (Lypholyte, Multilyte, TPN Electrolytes). Dextrose and electrolyte solutions such as Plasma-Lyte R and 5% dextrose are used as a parenteral source of electrolytes, calories, or water for hydration. Invert sugar-electrolyte solutions, such as Multiple Electrolytes and Travert 5% and 10%, contain equal parts of dextrose and fructose and are used as a source of calories and hydration. 

Combined electrolyte solutions are available for oral and IV administration. The IV solutions contain various electrolytes and dextrose. The amount of electrolytes, given as milliequivalents per liter (mEq/L), also varies. The IV solutions are used to replace fluid and electrolytes that have been lost and to provide calories by means of their carbohydrate content. Examples of IV electrolyte solutions are dextrose 5% with 0.9% NaCl, lactated Ringer s injection, Plasma-Lyte, and 10% Travert (invert sugar—a combination of equal parts of fructose and dextrose) and Electrolyte No. 2. 

RINGER S INJECTION LACTATED USP 1000ML BAG 12 BAGS PER PACKAGE 6505013306267 PG 6.30 ... 

RINGER S INJECTION LACTATED USP 500ML BAG 24 BAGS PER PACKAGE 6305013306266 PG 15.00 ... 

An intravenous fluid of 1000 mL of Ringer s Injection was started in a patient at 8 00 a.m. and was scheduled to run for 12 hours. At 3 00 p.m. it was found that 800 mL of the fluid remained in the bottle. At what rate of flow should the remaining fluid be regulated using an IV set that delivers 15 drops per mL in order to complete the administration of the fluid in the scheduled time ... 

Potassium phosphate injection Ringer s injection Lactated ringer s injection Sodium acetate injection Sodium bicarbonate injection Sodium chloride injection Sodium lactate injection Sodium phosphate injection... 

Compatibility/Stability- Esmolol, at a final concentration of 10 mg/mL, is compatible with the following solutions and is stable for 24 hours or more at controlled room temperature or under refrigeration 5% dextrose injection 5% dextrose in Lactated Ringer s injection 5% dextrose in Ringer s injection 5% dextrose and 0.9% or 0.45% sodium chloride injection Lactated Ringer s injection potassium chloride (40 mEq/L) in 5% dextrose injection 0.9% or 0.45% sodium chloride injection. 

Sodium Chloride Injection, Dextrose 5% in 0.45% Sodium Chloride, Ringer s or Lactated Ringer s Injection). Infuse slowly IV over not less than 15 minutes, 30 minutes before beginning cancer chemotherapy repeat every 2 hours for 2 doses, then every 3 hours for 3 doses. 

IV infusion (20 or 40 mg) over 10 to 30 minutes A solution for IV infusion is prepared by first reconstituting the contents of 1 vial with 5 ml of 0.9% sodium chloride injection, lactated Ringer s injection, or 5% dextrose injection, and further diluting the resulting solution to a final volume of 50 ml. The solution (admixture) should be administered as an IV infusion over a period of 10 to 30 minutes. 

IV administration Administer over a period of 30 to 120 minutes. Do not use IV infusion bag in series connections. Do not introduce additives into this solution. Do not administer concomitantly with another drug administer each drug separately. Compatible IV solutions 5% dextrose injection, 0.9% sodium chloride injection lactated Ringer s injection. 

Remifentanil Hydrochloride Remifentanil hydrochloride should not be mixed with lactated Ringer s injection, 5% glucose injection, or blood products. Solutions of remifentanil hydrochloride are incompatible with chlorpromazine hydrochloride, remifentanil, cefoperazone sodium, and amphotericin.84... 

A. Dilute before intravenous injection to a final ooncentration of 10 mg/mL, with 5% dextrose, laotated Ringer s injection, or saline solutions. 

Among single drug component studies, usual vehicles for dilution are 5% dextrose (D5W), 0.9% sodium chloride (normal saline, NS), aqueous buffers, peritoneal dialysis fluid, nonaqueous solvents, water for injection, phosphate-buffered saline, bacteriostatic water for injection, bacteriostatic sodium chloride. Ringer s injection, and lactated Ringer s. Stability studies can also be carried out on the drug product solution as such or in specific containers or injection devices. Solutions and suspensions can also be prepared extemporaneously and stability tested to show worthiness for oral, ophthalmic, or rectal administration. The following is an example of the first... 

---